Companies: 10,795·Total market cap: $144.5T
BioCardia, Inc.

BioCardia, Inc.

BCDANASDAQHealthcare● Active
$0.92
$-0.11(-10.68%)
Market Cap$5334911
P/E Ratio
52W High$2.45
52W Low$0.84

BioCardia, Inc. (BCDA) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

BCDA · net income · updated Jun 9, 2026

Core profitability metrics

Net income was −$8.2M for FY2025 (fiscal year ending 2025-12-31), down 3.5% year-over-year. Net profit margin was —. Based on available data, BioCardia, Inc. has been profitable since at least 2011.

FY2025 Net Income−$8.2M▼ -3.5% YoY
Trailing 12M (TTM)−$7.8Mtrailing 4 quarters sum
Net Profit Margin
YoY Change-3.5%
5-Year CAGRN/AN/A — contains loss years
FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0
Source: FMP /income-statement · US GAAP · USDUpdated: Jun 9, 2026

Annual net income history

Net IncomeNet LossNet Margin %★ First Profit: 2011

▸ FMP /income-statement · Annual · BCDA net income history · BCDA profit margin

Annual net income data

Fiscal YearNet IncomeYoY ChangeNet Margin
FY2025Loss−$8.2M▼ 3.5%
FY2024Loss−$7.9M▲ +31.3%-13700.0%
FY2023Loss−$11.6M▲ +2.8%-2425.8%
FY2022Loss−$11.9M▲ +5.7%-880.7%
FY2021Loss−$12.6M▲ +15.9%-1243.5%

Net income vs peers (Healthcare)

#CompanyNet IncomeYoY
#1
BioCardia, Inc.
BioCardia, Inc.YOU
BCDA
−$8.2M-3.5%
#2
Johnson & Johnson
Johnson & Johnson
JNJ
$26.80B+90.6%
#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$20.64B+94.9%
#4
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$12.06B-16.3%
#5
AbbVie Inc.
AbbVie Inc.
ABBV
$4.23B-1.2%
Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

BioCardia, Inc. (BCDA) reported net income of −$8.2M for FY2025 (fiscal year ending 2025-12-31), down 3.5% year-over-year. The net profit margin was — — meaning the company kept $— of every dollar of revenue as profit.

Based on available data, BioCardia, Inc. has been profitable since at least 2011. Net income reached a peak of $9.7M in FY2011. Data available for 15 fiscal years.

BioCardia, Inc.'s net profit margin was — for FY2025, based on the latest annual results.

Investors sometimes search for "BioCardia, Inc. net worth" — the company's market capitalization is a separate figure from BCDA net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Frequently asked questions

BCDA net income · 4 questions

BioCardia, Inc. is not currently profitable on an annual basis. The company reported a net loss of $8.2M for FY2025.

is BCDA profitabledoes BCDA make a profitBCDA profitabilityBCDA profitable company

Source: FMP /income-statement · GAAP · BioCardia, Inc. · BioCardia, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026